At a glance
- Originator Zambon Group SpA
- Class Anti-ischaemics; Antihypertensives; Heart failure therapies; Peripheral vasodilators
- Mechanism of Action Dopamine D1 receptor agonists; Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension; Ischaemic heart disorders
Most Recent Events
- 08 Oct 2001 No-Development-Reported for Congestive heart failure in Europe (Unknown route)
- 08 Oct 2001 No-Development-Reported for Hypertension in Europe (Unknown route)
- 08 Oct 2001 No-Development-Reported for Ischaemic heart disorders in Europe (Unknown route)